Quadrant Capital »

Peregrine Pharmaceuticals shares owned by Quadrant Capital

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2k 494 6.50
2023-09-30 $359 38 9.45
2023-06-30 $1.7k 120 13.98
2023-03-31 $3.6k 190 18.76
2022-12-31 $1.7k 120 13.77
2022-09-30 $0 17 0.00